Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke
NCT02526225Phase 2Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- Feb 2016
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Ginkgo diterpene lactone meglumine in ischemic stroke, sponsored by Beijing Tiantan Hospital. Started Feb 2016; status: completed.
02
Drugs
Ginkgo diterpene lactone meglumine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02526225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02526225.